Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tubes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00041080
What this trial is testing

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer+2 more
National Cancer Institute (NCI) 139
Not applicableEnded earlyNCT00287482
What this trial is testing

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

Who this might be right for
Ovarian CancerBreast Cancer
Women and Infants Hospital of Rhode Island 20
Testing effectiveness (Phase 2)Study completedNCT00856180
What this trial is testing

Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT00748527
What this trial is testing

Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Cancer Research UK 134
Testing effectiveness (Phase 2)UnknownNCT03321188
What this trial is testing

Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer
Andrea Jewell 20
Large-scale testing (Phase 3)Study completedNCT02891824
What this trial is testing

ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 614
Testing effectiveness (Phase 2)Ended earlyNCT00085384
What this trial is testing

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00053833
What this trial is testing

S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
SWOG Cancer Research Network 2
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03355976
What this trial is testing

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more
Brown University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07023484
What this trial is testing

Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
The University of Hong Kong 126
Testing effectiveness (Phase 2)Ended earlyNCT01035658
What this trial is testing

Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
SCRI Development Innovations, LLC 22
Not applicableStudy completedNCT05047926
What this trial is testing

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Advanced Ovarian CarcinomaStage IIIC Fallopian Tube Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8+4 more
Mayo Clinic 90
Testing effectiveness (Phase 2)Study completedNCT00039585
What this trial is testing

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT00189371
What this trial is testing

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

Who this might be right for
Epithelial Ovarian Cancer, Fallopian Tube or PeritoneumPlatinum Sensitve RelapseAnemia
AGO Study Group 300
Large-scale testing (Phase 3)Study completedNCT01376349
What this trial is testing

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Who this might be right for
Breast CancerGynecologic Cancer
Alliance for Clinical Trials in Oncology 464
Testing effectiveness (Phase 2)Study completedNCT01447706
What this trial is testing

MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Merrimack Pharmaceuticals 223
Testing effectiveness (Phase 2)Looking for participantsNCT07022535
What this trial is testing

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
The University of Hong Kong 18
Large-scale testing (Phase 3)UnknownNCT03373058
What this trial is testing

Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 310
Testing effectiveness (Phase 2)Ended earlyNCT04442126
What this trial is testing

NM21-1480 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerColorectal Cancer+6 more
Numab Therapeutics AG 52
Next Page